A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Salmeterol


Combination inhalers can cut lung function decline  -  25 May 2007
Healthcare Republic (press release),Findings from the 'Towards a revolution in COPD health' (TORCH) study suggest that treatment with a salmeterol/fluticasone propionate inhaler slows the rate

Combination inhalers can cut lung function decline  -  25 May 2007
Healthcare RepublicFindings from the 'Towards a revolution in COPD health' (TORCH) study suggest that treatment with a salmeterol/fluticasone propionate inhaler slows the rate

Advair Benefits Patients with COPD – New Study Shows Salmeterol ...  -  May 22, 2007
Best Syndication,Some of the patients were given either the long-acting beta2-agonist salmeterol (Serevent) or the inhaled corticosteroid fluticasone propionate (Flovent)

Drug Treatment Slows Decline In Lung Function In COPD Patients ...  -  May 24, 2007
Science Daily (press release)The study of 6112 patients from 42 countries found that those treated with salmeterol/fluticasone propionate (Advair) had a slower rate of lung function

ATS: COPD Drugs Slow Disease Progression, Study Confirms  -  May 22, 2007
MedPage Today,Fluticasone proprionate plus salmeterol (Advair) reduced the decline in forced expiratory volume (FEV 1 ) by 16 mL per year compared with placebo (P<0.001),

Research highlights from Thoracic Society Conference  -  May 21, 2007
SpiritIndia,National Jewishm Medical and Research Center faculty present research on asthma and obesity -- asthma, perception vs. reality -- salmeterol -- asthma and

Good news for for people with mild, persistent asthma  -  May 20, 2007
News-Medical.net,Two other groups took alternative therapies: either a combination of fluticasone propionate and salmeterol in a single inhaler (Advair Discus) once daily or

Clinical Trial Data For Perforomist Inhalation Solution Presented ...  -  May 23, 2007
Medical News Today (press release),Data from a large placebo-controlled US study comparing the safety of another LABA (salmeterol) or placebo added to usual asthma therapy showed an increase

New once-daily treatment options for Asthma  -  May 16, 2007
South Asian Women's Forum,Another third took a combination of fluticasone propionate and salmeterol in a single inhaler (Advair Discus) once daily and the rest took the oral

Mild asthma can be controlled with once-a-day treatment  -  May 16, 2007
News-Medical.net,Salmeterol, used in the combination therapy, is a long-acting bronchodilator, or a drug that relaxes and opens the airways.

Once a day treatment may be option for mild asthma cases  -  May 16, 2007
CBC Toronto,The other two groups took either a combination of fluticasone propionate and salmeterol, a longer-acting drug that relaxes and opens airways,

New Once-A-Day Treatment To Reduce Symptoms Of Mild Asthma  -  May 17, 2007
AHNOne third of the group continued to take Flovent twice a day for 16 weeks while another third took a combination of fluticasone propionate and salmeterol in

Clinical Trial Data for Perforomist Inhalation Solution to be ...  -  May 17, 2007
PharmaLive.com (press release),Data from a large placebo-controlled US study comparing the safety of another LABA (salmeterol) or placebo added to usual asthma therapy showed an increase

New Options for Mild Asthma  -  May 16, 2007
Ivanhoe,Participants took either Flovent twice a day for 16 weeks; a combination of fluticasone propionate and salmeterol in a single inhaler (Advair® Discus) once

Could You Do Well with Less Asthma Medication?  -  May 18, 2007
About - News & Issues,The medication was changed, however, from twice a day fluticasone to once a day fluticasone-salmeterol combination, or Advair.

CHRB Cites Biancone for Class 3 Violation  -  May 12, 2007
BloodHorse,Salmeterol is a beta-2 agonist similar to clenbuterol and albuterol, bronchodilators approved for use in the horse. Iron Butterfly finished second in the

GSK Supports GINA's 2007 World Asthma Day - 'You Can Control Your ...  -  May 2, 2007
Medical News Today (press release),SeretideTM (salmeterol/fluticasone propionate - GlaxoSmithKline) is the most widely prescribed combination treatment in the UK.3

Asthma must be treated as serious  -  May 24, 2007
City Vision,Long-acting ones include salmeterol and formoterol and are used together with an anti-inflammatory drug every day.Work quickly and last for varying periods

FDA Advisory Committee Finds Substantial Evidence to Support ...  -  May 9, 2007
Pharmaceutical Processing,An Advisory Committee to the FDA recently unanimously agreed (11 to 0) that GlaxoSmithKline's Advair Diskus® 500/50 (fluticasone propionate and salmeterol

Higher Dose Advair Questioned By FDA Panel  -  May 2, 2007
Post Chronicle...said the study did show that Advair caused a "meaningful decrease" in COPD exacerbations, and that the drug had an advantage over salmeterol alone,

Advair Doesn't Boost COPD Survival  -  May 1, 2007
Wall Street JournalAdvair is a combination of fluticasone and salmeterol and is aimed at long-term maintenance of COPD symptoms. The drug is also used to treat asthma.

FDA Advisory Committee Finds Substantial Evidence to Support ...  -  May 2, 2007
Compliance Home,...to 0) that GlaxoSmithKline's Advair Diskus(R) 500/50 (fluticasone propionate and salmeterol inhalation powder) demonstrated a significant reduction in

FDA panel not sure GSK's Advair increases COPD survival  -  May 2, 2007
Pharma Times (subscription),Additionally, they voted unanimously that Advair 500/50 provides substantial advantages over salmeterol in treating the disease, also known as smoker's

Higher dose Advair questioned by FDA panel  -  May 3, 2007
Monsters and Critics.com,...said the study did show that Advair caused a 'meaningful decrease' in COPD exacerbations, and that the drug had an advantage over salmeterol alone,

Higher dose Advair questioned by FDA panel  -  May 2, 2007
ImediNews,...said the study did show that Advair caused a meaningful decrease in COPD exacerbations, and that the drug had an advantage over salmeterol alone,

Viable asthma alternatives  -  May 19, 2007
Health24.com,People in both the fluticasone and the fluticasone plus salmeterol group fared about the same, with both groups experiencing about a 20 percent treatment

Simpler asthma treatment options found effective  -  May 17, 2007
News from Washington University in St. Louis,These patients took once-daily inhaled fluticasone plus salmeterol (Advair 100®). Salmeterol is a long-acting drug that dilates the lung's airways.

New Ways to Quell Mild Persistent Asthma  -  May 16, 2007
MedPage Today,The researchers found that 20.2% of those continuing treatment and 20.4% of those switched to fluticasone/salmeterol had treatment failure, compared with

Treatment of Mild Persistent Asthma  -  May 16, 2007
New England Journal of Medicine (subscription),Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction: a randomized, double-blind trial.

Asthma treatments are promising  -  May 21, 2007
Ventura County Star (subscription),For 16 weeks, they received either their two daily puffs of steroids, one daily pill or one daily puff of the combo drug containing steroids plus salmeterol

FDA Advisory Committee Finds Substantial Evidence To Support ...  -  May 8, 2007
Medical News Today (press release),...today unanimously agreed (11 to 0) that GlaxoSmithKline's Advair Diskus® 500/50 (fluticasone propionate and salmeterol inhalation powder) demonstrated a

FDA Advisory Committee finds substantial evidence to support Advair  -  May 2, 2007
WebWire (press release),...today unanimously agreed (11 to 0) that GlaxoSmithKline’s Advair Diskus® 500/50 (fluticasone propionate and salmeterol inhalation powder) demonstrated a

Analysis: Asthma patients can cut dose  -  May 17, 2007
United Press International...one daily dose of Advair Diskus (fluticasone plus salmeterol), and the remaining 166 patients to receive a once-daily dose of Singulair (montelukast).

Asthma sufferers get room to breathe  -  May 17, 2007
Independent Online,About a third continued on the twice-daily treatment, another third took a once-daily combination of fluticasone plus salmeterol, sold as Advair by

Spain's Faes posts healthy increase in profits  -  May 17, 2007
Pharma Times (subscription),...but its bestsellers included the asthma treatment Inaladuo/Maizar (salmeterol/fluticasone), the antidepressant Motiván (paroxetine), the ulcerative

Thor's Echo returning  -  May 11, 2007
Daily Racing Form (subscription),7, tested positive for the bronchodilator salmeterol in a post-race urine sample. A hearing has not been scheduled in the case, the racing board said in a

Asthma? No big deal, life goes on  -  May 5, 2007
Hindustan Times,...“A combination of the inhaled steroid fluticasone propionate and the long-acting beta 2-agonist salmeterol is very effective,� says Dr Vikram.

The Health Edition  -  May 1, 2007
Wall Street Journal...and a combination of the steroid drugs fluticasone and salmeterol (known by the brand name Advair), which can also fight inflammation.

GSK hit by strong sterling but underlying growth is good  -  26 Apr 2007
Pharma Times (subscription),Pharmaceutical sales increased 3% to £4.81 billion, with Advair/Seretide (salmeterol and fluticasone) for asthma and chronic obstructive pulmonary disease

New Publications Confirm Clinical And Scientific Benefits Of  -  Apr 23, 2007
Pharmaceutical Online (press release),Formoterol is a unique bronchodilator that is rapid in effect, unlike salmeterol, and long lasting. Salmeterol does not have the properties that enable it

Combination Inhaler Therapy for Chronic Obstructive Pulmonary Disease  -  Apr 16, 2007
Annals of Internal MedicineThe summary below is from the full report titled "Tiotropium in Combination with Placebo, Salmeterol, or Fluticasone–Salmeterol for Treatment of Chronic

Optimal Treatment of Chronic Obstructive Pulmonary Disease: The ...  -  Apr 16, 2007
Annals of Internal MedicineSimilar proportions of patients experienced an exacerbation across all 3 groups, but those who received tiotropium plus fluticasone–salmeterol had improved

Theravance Announces Positive Results of Clinical Program in ...  -  Apr 2, 2007
PipelineReview.com (press release),All doses studied of compound '444 (25, 100 and 400 mcg), dosed once a day, showed greater bronchodilator activity than salmeterol dosed twice a day,

Theravance Says Asthma Drugs Effective in Trials  -  Apr 3, 2007
Reuters.uk,Theravance said all tested doses of 444, given once a day, showed greater improvements in air passages expansion than salmeterol dosed twice a day,

Market Report -- In Play (THRX)  -  Apr 2, 2007
MSN MoneyIn the studies, '444, and '797, each given once daily, achieved clinically significant increases in bronchodilation at least equivalent to salmeterol given

Asthmatics Benefit from Warmed Bronchi  -  Apr 13, 2007
HealthandAge.comEffectiveness was measured by estimating the exacerbations occurring when long-acting beta-agonists (eg Salmeterol®) were withdrawn for a scheduled 2-week

Monday's Late Winners & Losers  -  Apr 2, 2007
TheStreet.com...significant increases in bronchodilation" (opening of the patients' airways) at least equal to the effects of salmeterol, an existing asthma treatment.

Theravance says asthma drugs effective in trials  -  Apr 2, 2007
Reuters.uk,Research) said on Monday that ongoing mid-stage trials of two experimental once-daily asthma drugs show they work at least as well as salmeterol,

Theravance says asthma drugs effective in trials  -  Apr 3, 2007
Therapeutics Daily (subscription) (press release),...ongoing mid-stage trials of two experimental once-daily asthma drugs show they work at least as well as salmeterol, a beta agonist given twice a day.

Theravance (THRX) Higher After Compound Shows Clinical Significance  -  Apr 2, 2007
StreetInsider.com (subscription),...each given once daily, achieved clinically significant increases in bronchodilation at least equivalent to salmeterol given twice daily.

Brovana Inhalation Solution Now Available by Prescription for ...  -  Apr 11, 2007
PharmaLive.com (press release),Data from a large placebo-controlled US study that compared the safety of another long-acting beta2-adrenergic agonist (salmeterol) or placebo added to

GlaxoSmithKline Receives Japanese Approval For Two Major New ...  -  Apr 23, 2007
Medical News Today (press release),GlaxoSmithKline (GSK) today announced that it has received approval for Seretide/Advair Diskus (salmeterol and fluticasone proprionate combination) and

Pharma Sector: Few Newsmakers Of The Week - Pfizer, Merck, Glaxo ...  -  Apr 6, 2007
Trading Markets,Salmeterol, which is used to treat asthma and similar respiratory diseases, is marketed by GlaxoSmithKline as Serevent. Theravance has been collaborating

Pedro Horrillo testet positivt etter Brabantse Pijl  -  Apr 20, 2007
Syklingens Verden,Pedro Horrillo has been using the aerosols Pulmicort (active ingredient: Budesonide) and Serevent (active ingredient: Salmeterol) ever since 1996 to

First Edition Cycling News  -  Apr 19, 2007
Cyclingnews.comHorrillo had an exemption for two drugs: Pulmicort (active ingredient: Budesonide) and Serevent (active ingredient: Salmeterol).

Japanese nod for GSK's Seretide/Advair and Arixtra  -  Apr 19, 2007
Pharma Times (subscription),Seretide/Advair (fluticasone and salmeterol), which will be marketed as Adonair Diskus 50/250mcg and 50/500mcg, has been approved for adult patients with

Broadway Actress/HIV Advocate, Sheryl Lee Ralph, Unveils Winning ...  -  Apr 16, 2007
Drug Newswire (press release),Levitra(R) (vardenafil HCl), Cialis(R) (tadalafil), Vfend(R) (voriconazole), Advair(R) (fluticasone propionate and salmeterol inhalation powder),

Icagen Announces Forms Drug Discovery and Development Expert Panel  -  Apr 10, 2007
Carolina Newswire (press release),He is a joint holder of patents on Salmeterol® and related molecules as long acting bronchodilators for the treatment of asthma, and led the Epivir® and

Icagen Announces Formation of Drug Discovery and Development ...  -  Apr 10, 2007
Genetic Engineering News (press release),He is a joint holder of patents on Salmeterol(R) and related molecules as long acting bronchodilators for the treatment of asthma, and led the Epivir(R) and

Biotech Day In Review: Cell Genesys Climbs On GVAX Results  -  Apr 4, 2007
Seeking Alpha,Theravance (THRX) said that two one-daily asthma drugs in Phase IIb trials each caused a response equal to twice-daily salmeterol.

Hot Bronchi Bring a Breath of Fresh Air to Severe Asthmatics  -  Mar 28, 2007
MedPage Today,...equivalent to more than 200 μg of beclomethasone (Beconase) and a long-acting β2-adrenergic agonist of 100 μg or more of salmeterol (Serevent).

Pharma Sector: Few Newsmakers Of The Week - Basilea Glaxo ...  -  25 Feb 2007
Trading Markets,Seretide/Advair sold as Advair Diskus is a combined treatment of fluticasone propionate, an inhaled corticosteroid and salmeterol, used to treat asthma and

Results From Landmark Study Suggest That Advair 500/50 Provides ...  -  Feb 22, 2007
PharmaLive.com (press release),The number of deaths while on treatment which were attributable to pneumonias was 7 in the placebo group, 9 in the salmeterol group, 13 in the fluticasone

NEJM lists benefits of GSK's Advair in COPD patients  -  Feb 22, 2007
Pharma Times (subscription),The latest data on Advair (salmeterol and fluticasone), published by the New England Journal of Medicine, comes from GSK's TORCH study which was conducted

Triple-Drug Combo for COPD Reduces Hospitalizations, Improves Lung...  -  Feb 20, 2007
Medscape (subscription)Salmeterol plus tiotropium did not differ significantly compared with single agent treatment. All-cause hospitalizations were also less frequent in the

Drug does little to cut lung disease death rate  -  Feb 21, 2007
Scientific AmericanIn addition to the 1533 who received Advair and 1524 who inhaled placebo, 1534 took fluticasone alone and 1521 only got salmeterol, a type of drug known as

Inhalers Beat Pill for Asthma  -  Jan 28, 2007
drkoop.comThe study compared the inhaled steroid Fluticasone (Flonase) to a fluticasone/Salmeterol (Serevent) combination (salmeterol is another type of inhaled drug

Two inhalers are better than one for common lung disease  -  Feb 19, 2007
CNW Telbec (Communiqués de presse),A third arm of the study looked at patients taking Spiriva(TM) plus salmeterol (one component of Advair(TM)). This combination was not as beneficial as

Astrazeneca Launches A Smarter Approach To Asthma Management In Europe  -  Feb 14, 2007
Medical News Today (press release),Symbicort SMART has been proven to reduce exacerbations by 39% compared with salmeterol / fluticasone combination and a separate reliever medication.1

Market Report -- In Play (GSK)  -  Feb 22, 2007
MSN Money...propionate and salmeterol inhalation powder) reduced their risk of death by 17.5% over three years compared to patients on placebo (p=0.052).

Video B-Roll Via Satellite - Results from landmark study suggest ...  -  Feb 21, 2007
Canada NewsWire (press release),...patients with Chronic Obstructive Pulmonary Disease (COPD) who took Advair(R) Diskus(R) 50/500 mcg (salmeterol and fluticasone propionate dry powder for

Sepracor Announces Fourth Quarter and Full Year 2006 Results  -  Jan 31, 2007
Business Wire (press release),The study evaluated airway function improvement with BROVANA and salmeterol (SEREVENT ® ) MDI compared with placebo over a period of 12 weeks in patients

lower steroid dose for asthmatic kids  -  Feb 13, 2007
NorthJersey.com,...or salmeterol) in the morning and Serevent again at night; or to take a chewable tablet of Singulair (montelukast), a leukotriene modifier, at night.

Pipeline paying dividends as GSK posts strong earnings rise  -  Feb 9, 2007
Pharma Times (subscription),Advair/Seretide (salmeterol and fluticasone) for asthma and chronic obstructive pulmonary disease grew 9% to £862 million in the quarter, and GSK noted that

World drug retail sales enjoy 5% growth  -  Jan 29, 2007
Pharma Times (subscription),Third was GlaxoSmithKline's asthma drug Advair/Seretide (salmeterol and fluticasone), followed by Sanofi-Aventis' antiplatelet drug, Plavix (clopidogrel),

Exacerbations In Severe COPD Reduced By Combination Therapy  -  18 Jan 2007
Medical News Today (press release),The researchers treated 487 patients with salmeterol, a long-acting bronchodilator, and gave 507 a combination therapy of salmeterol and fluticasone

“Fatal exacerbationâ€? among certain asthma sufferers  -  Jan 11, 2007
Destination Santé,More than 16 months ago Destination Santé revealed that salmeterol and formoterol had been placed on the Index by the US Food and Drug Administration (FDA)

Beta-Agonists may cause thousands of asthma-related deaths each year  -  Jan 1, 2007
Health SentinelLong-acting beta-agonists, such as salmeterol (Serevent) and formoterol (Foradil) are used to control moderate to severe asthma and prevent nighttime

Combination Therapy Reduces COPD Exacerbations  -  Jan 15, 2007
MedPage Today,Among patients with severe COPD prone to frequent exacerbations, Advair Diskus 500/50 (fluticasone plus salmeterol) reduced these episodes by 35% compared

Total Asthma Control Yields Best Quality of Life  -  Jan 4, 2007
Medscape (subscription)The efficacy analysis showed that salmeterol/fluticasone improved the odds of total asthma control compared with fluticasone alone.

TUE an alibi: Expert  -  Dec 29, 2006
Times of India,Besides salbutamol, formotrol, terbutaline and salmeterol are the other drugs used to treat asthmatics. There is an increasing tendency among athletes to

SkyePharma aims for $82m with sale of injectable business  -  Jan 10, 2007
In-PharmaTechnologist.com,The only two approved combination drugs are GlaxSmithKline's Advair/Seretide (salmeterol and fluticasone) and AstraZeneca's Symbicort (budesonide and

UNIDO submits Sina Darou Laboratories Co project to EXCOM  -  Jan 9, 2007
Islamic Republic News Agency,...in its manufacturing line; namely, Salbutamol 100 microgram, Beclomethasone DP 250 microgram, Salmeterol 25 microgram and Cromolyn Sodium 1 milligram.

Glaxo withdraws patent plea for asthma drug  -  Dec 21, 2006
Times of India,Glaxo has withdrawn its patent application on the combination of fluticasone and salmeterol after generic manufacturer Cipla filed a pre-grant opposition.

NFL plays hardball better than MLB  -  Dec 9, 2006
Boston Herald,...“Advair contains both the steroid fluticasone and the long-acting beta-agonist salmeterol. Hollis’ urine drug test in August of 2006 was positive for

Who prescribed drug?  -  Dec 7, 2006
Biloxi Sun Herald,Advair contains both the steroid fluticasone and the long acting beta agonist salmeterol, both of which aren't on the banned substance list.

NFL suspends Thomas for violating steroids policy  -  Dec 5, 2006
San Jose Mercury News,Thomas was taking Advair, which contains a steroid fluticasone and a beta agonist salmeterol, and an albuterol inhaler at the time of the positive test.

Glaxo withdraws patent plea for asthma drug  -  Dec 21, 2006
Times of India,Glaxo has withdrawn its patent application on the combination of fluticasone and salmeterol after generic manufacturer Cipla filed a pre-grant opposition.

Carriers for DPIs: formulation and regulatory challenges  -  Dec 13, 2006
Pharmaceutical Technology Europe,...<1% drug concentration in the blend; for example, Miflonide (budesonide); Ventolin, Pulvinal (both salbutamol); and Seretide (salmeterol/fluticasone). 1

Asthma: 3 steps to better asthma control  -  Dec 12, 2006
MayoClinic.comExamples include salmeterol (Serevent) or formoterol (Foradil). A combination of inhaled corticosteroids and long-acting beta-2 agonists.

Research and Markets: Cipla Manufactures Apis And Formulation ...  -  Nov 27, 2006
PharmaLive.com (press release),Other firsts have included propranolol, ondansetron, salmeterol, montelukast, fluticasone propionate and doxazosin. In 2006, the company announced it was


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional